{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:14:00Z","timestamp":1791933240112,"version":"4.3.4"},"reference-count":64,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>Ambulatory chemotherapy allows the delivery of short and extended chemotherapy infusions through a portable pump from the comfort of patients\u2019 homes. It is essential to offer it for suitable candidates to ensure both their safety and the success of the treatment session. This requires a delicate balance between clinical assessment and patient acceptance.<\/jats:p>\n                  <jats:p>The two main components of this treatment modality are the pump and the access device.<\/jats:p>\n                  <jats:p>There are several pump designs and mechanisms on the market, with the latest being the portable disposable elastomeric one.<\/jats:p>\n                  <jats:p>Clinicians along with a multidisciplinary medical team often decide upon the type of access device; patients are also involved whenever shared decision making is practiced.<\/jats:p>\n                  <jats:p>Despite some reports of pump programming errors or malfunctions, research is underway to find innovative solutions to support its use.<\/jats:p>","DOI":"10.1177\/1078155220985916","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T01:37:36Z","timestamp":1611020256000},"page":"962-973","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["Ambulatory chemotherapy: Past, present, and future"],"prefix":"10.1177","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-9776","authenticated-orcid":false,"given":"Racha","family":"Sabbagh Dit Hawasli","sequence":"first","affiliation":[{"name":"Faculty of Engineering and Computing, School of Pharmacy and Chemistry, Kingston University, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Barton","sequence":"additional","affiliation":[{"name":"Faculty of Engineering and Computing, School of Pharmacy and Chemistry, Kingston University, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Nabhani-Gebara","sequence":"additional","affiliation":[{"name":"Faculty of Engineering and Computing, School of Pharmacy and Chemistry, Kingston University, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"bibr1-1078155220985916","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2014.23.Sup2.S36"},{"key":"bibr2-1078155220985916","unstructured":"Boothroyd L, Lehoux P. Home-based chemotherapy for cancer issues for patients, caregivers and the health care system AGENCE D\u2019\u00c9VALUATION DES TECHNOLOGIES ET DES MODES D\u2019INTERVENTION EN SANT\u00c9, www.aetmis.gouv.qc.ca (accessed 4 July 2020)."},{"key":"bibr3-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-010-0917-7"},{"key":"bibr4-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1159\/000335879"},{"key":"bibr5-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059118"},{"key":"bibr6-1078155220985916","unstructured":"Sabbagh Dit Hawasli R, Barton S, Kayyali R, et\u00a0al. Diffusion of innovation in ambulatory chemotherapy: case study in Lebanon. In: Goldspiel B, editor. Platform presentations concurrent session: research 5. JOPP, https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/1078155217691227 (2017, accessed 21 December 2020)."},{"key":"bibr7-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-172X.2010.01876.x"},{"key":"bibr8-1078155220985916","unstructured":"Hospitals NHSTLT. Ambulatory Care. Vol. 2018. http:\/\/www.leedsth.nhs.uk\/a-z-of-services\/leeds-cancer-centre\/your-treatment\/chemotherapy\/ambulatory-care\/ (2018, accessed 21 December 2020)."},{"key":"bibr9-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1292-8"},{"key":"bibr10-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12340"},{"key":"bibr11-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2627-7"},{"key":"bibr12-1078155220985916","unstructured":"Moog I. Understanding How Different Infusion Pump Technologies Impact Flow Accuracy, Resolution, and Continuity WHY YOUR CHOICE OF INFUSION PUMP MATTERS TO PATIENT OUTCOMES Understanding How Different Infusion Pump Technologies Impact Flow Accuracy, Resolution, a, https:\/\/www.curlinpump.com\/wp-content\/uploads\/2020\/02\/MD-58199-Rev-B-Resolution-and-Continuity-of-Flow-Whitepaper.pdf (2019, accessed 21 December 2020)."},{"key":"bibr13-1078155220985916","unstructured":"Backler C. Which Ambulatory Infusion Pump Is Best for 5-FU? | ONS Voice. Oncology Nursing Society, https:\/\/voice.ons.org\/news-and-views\/which-ambulatory-infusion-pump-is-best-for-5-fu (2019, accessed 21 December 2020)."},{"key":"bibr14-1078155220985916","first-page":"211","volume":"63","author":"Dorr RT","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"bibr15-1078155220985916","unstructured":"Medical S. CADD Prizm Ambulatory Infusion Pump. Vol. 2018, http:\/\/www.myoptionone.com\/wp-content\/uploads\/Prizm-VIP-Technical-Manual.pdf (2015, accessed 21 December 2020)."},{"key":"bibr16-1078155220985916","unstructured":"Medical S. CADD\u00ae-Solis Ambulatory Infusion Pump. Vol. 2018, https:\/\/www.smiths-medical.com\/products\/infusion\/ambulatory-infusion\/ambulatory-infusion-pumps\/caddsolis-ambulatory-infusion-pump (2018, accessed 21 December 2020)."},{"key":"bibr17-1078155220985916","unstructured":"Baxter Healthcare Corporation. Operator\u2019s Manual SIGMA SPECTRUM INFUSION PUMP WITH MASTER DRUG LIBRARY 35700BAX2 Pump Operating Software Version 8.00 For use with Master Drug Library Version 8 ii Manual 41018v0800 SIGMA Spectrum Infusion System Revision M Operator\u2019s Manual iii SIGMA Sp, www.sigmapumps.com (2018, 21 December 2020)."},{"key":"bibr18-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0232-1"},{"key":"bibr19-1078155220985916","unstructured":"JBowers. DHHS Letterhead, https:\/\/www.fda.gov\/regulatory- (accessed 21 December 2020)."},{"key":"bibr20-1078155220985916","unstructured":"HomeStar. H. Chemotherapy, https:\/\/www.slhn.org\/-\/media\/slhn\/Conditions-Services\/Pharmacy-Services\/pdf\/HomeStarPharmacy-CADDChemo (accessed 21 December 2020)."},{"key":"bibr21-1078155220985916","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050408"},{"key":"bibr22-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1097\/00003643-200406002-00384"},{"key":"bibr23-1078155220985916","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp110296"},{"key":"bibr24-1078155220985916","unstructured":"of South Australia G. Elastomeric Infusor Devices for Medication Administration. Vol. 2018, http:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/protecting+public+health\/alerts\/medication+alerts\/elastomeric+infusor+devices+for+medication+administration (2018, accessed 21 December 2020)."},{"key":"bibr25-1078155220985916","unstructured":"Your Ambulatory Infusion Pump (AIP), www.uhnpatienteducation.ca (2016, accessed 21 December 2020)."},{"key":"bibr26-1078155220985916","unstructured":"Corporation BH. Patient Guide Baxter Infusor Range | The Home Calling, https:\/\/www.thehomecalling.com\/patient-guide-baxter-infusor-range (accessed 21 December 2020)."},{"key":"bibr27-1078155220985916","unstructured":"of Health USD, Food HS, Administration D. Infusion Pumps. Vol. 2018, https:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/GeneralHospitalDevicesandSupplies\/InfusionPumps\/ (2018, accessed 21 December 2020)."},{"key":"bibr28-1078155220985916","unstructured":"Dictionary.com. User Interface. Vol. 2018, http:\/\/www.dictionary.com\/browse\/user-interface?s=t (2018, accessed 21 December 2020)."},{"key":"bibr29-1078155220985916","unstructured":"Perspectives MF. Updates Report on Infusion Pumps; Pump Failures. Vol. 2018, http:\/\/medicallawperspectives.com\/Content_Weekly\/FDA-Updates-Report-on-Infusion-Pumps-Pump-Failures.aspx (accessed 21 December 2020)."},{"key":"bibr30-1078155220985916","unstructured":"FDA \u2013 center for devices and radiological health. White paper: infusion pump improvement initiative. Vol. 2018. U.S. Food and Drug Administration, https:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/GeneralHospitalDevicesandSupplies\/InfusionPumps\/ucm205424.htm (2017, accessed 21 December 2020)."},{"key":"bibr31-1078155220985916","unstructured":"Institute for Safe Medication Practices. Accidental Overdoses Involving Fluorouracil Infusions | Institute For Safe Medication Practices. Institute for Safe Medication Practices, https:\/\/www.ismp.org\/resources\/accidental-overdoses-involving-fluorouracil-infusions (2015, accessed 21 December 2020)."},{"key":"bibr32-1078155220985916","first-page":"313","volume":"36","author":"Grissinger M.","year":"2011","journal-title":"P T"},{"key":"bibr33-1078155220985916","unstructured":"Institute for Safe Medication Practices. Fluorouracil Error Ends Tragically, But Application of Lessons Learned Will Save Lives | Institute For Safe Medication Practices. Institute for Safe Medication Practices, https:\/\/www.ismp.org\/resources\/fluorouracil-error-ends-tragically-application-lessons-learned-will-save-lives (2007, accessed 21 December 2020)."},{"key":"bibr34-1078155220985916","unstructured":"NHS. Design for patient safety A guide to the design of electronic infusion devices. Vol. 2018, http:\/\/www.nrls.npsa.nhs.uk\/resources\/?EntryId45=68534 (2010, accessed 21 December 2020)."},{"key":"bibr35-1078155220985916","first-page":"CD013191","volume":"12","author":"Dinnes J","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr36-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv296"},{"key":"bibr37-1078155220985916","first-page":"e162\u2013193","volume":"52","author":"O\u2019Grady N","year":"2017","journal-title":"Clin Infect Dis"},{"key":"bibr38-1078155220985916","first-page":"e298\u2013304","volume":"25","author":"LeVasseur N","year":"2018","journal-title":"Curr Oncol"},{"key":"bibr39-1078155220985916","unstructured":"American Society of Clinical Oncology (ASCO). Catheters and Ports in Cancer Treatment | Cancer.Net, https:\/\/www.cancer.net\/navigating-cancer-care\/how-cancer-treated\/chemotherapy\/catheters-and-ports-cancer-treatment (accessed 21 December 2020)."},{"key":"bibr40-1078155220985916","doi-asserted-by":"publisher","DOI":"10.4081\/pr.2012.e28"},{"key":"bibr41-1078155220985916","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v7.i1.87"},{"key":"bibr42-1078155220985916","unstructured":"Chemocare- Cleveland Clinic. Injection Site Reactions - Managing Side Effects \u2013 Chemocare, http:\/\/chemocare.com\/chemotherapy\/side-effects\/injection-site-reactions.aspx (accessed 21 December 2020)."},{"key":"bibr43-1078155220985916","unstructured":"European Medicines Agency. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS, https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/yondelis-epar-product-information_en.pdf (accessed 21 December 2020)."},{"key":"bibr44-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.5733"},{"key":"bibr45-1078155220985916","unstructured":"Memorial Sloan Kettering Cancer Center. Continuous Infusion with Your Elastomeric Pump, https:\/\/www.mskcc.org\/cancer-care\/patient-education\/continuous-infusion-elastomeric-pump (2019, accessed 21 December 2020)."},{"key":"bibr46-1078155220985916","unstructured":"Centre Hospitalier de l\u2019Universite de Montreal.\n                      Taking medication with a portable infusion pump \u2013 Central venous catheter without valve (irrigation with heparin).\n                      Canada: Author, 2019."},{"key":"bibr47-1078155220985916","unstructured":"NHS Pan Birmingham Cancer Network. Guidelines for the Care of Venous Catheters for the Administration of Anticancer Medication, www.royalmarsdenmanual.com\/SpringboardWebApp\/userfiles\/rmm8e\/file\/c03_Web.pdf (2015, accessed 21 December 2020)."},{"key":"bibr48-1078155220985916","unstructured":"The Hospital for Sick Children (SickKids). Venous Access Devices, http:\/\/www.sickkids.ca\/Nursing\/Education-and-learning\/Nursing-Student-Orientation\/module-two-clinical-care\/paediatric-iv-therapy\/Venous-Access-Devices\/index.html (accessed 21 December 2020)."},{"key":"bibr49-1078155220985916","unstructured":"Institue D-FC. Instructions to disconnect CADD pump and flush port-a-cath, https:\/\/www.dana-farber.org\/health-library\/articles\/instructions-to-disconnect-cadd-pump-and-flush-port-a-cath\/ (accessed 21 December 2020)."},{"key":"bibr50-1078155220985916","unstructured":"J, Hopkins Medicine. Specialty ISR, | and Johns Hopkins HCG. https:\/\/www.hopkinsmedicine.org\/homecare\/services\/infusion\/patient_resources.html (accessed 21 December 2020)."},{"key":"bibr51-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220963527"},{"key":"bibr52-1078155220985916","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5151.164940"},{"key":"bibr53-1078155220985916","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S108047"},{"key":"bibr54-1078155220985916","unstructured":"O\u2019Grady N, Alexander M, Burns L, et\u00a0al. BSI | Guidelines Library | Infection Control | CDC. Centers for Disease Control and Prevention (CDC) p. 80, https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/bsi\/index.html (2017, accessed 21 December 2020)."},{"key":"bibr55-1078155220985916","unstructured":"How the COVID-19 Pandemic Is Propelling the Delivery of Home Care for Patients With Cancer - The ASCO Post, https:\/\/www.ascopost.com\/issues\/may-25-2020\/how-the-covid-19-pandemic-is-propelling-the-delivery-of-home-care-for-patients-with-cancer\/ (accessed 21 December 2020)."},{"key":"bibr56-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2007.04324.x"},{"key":"bibr57-1078155220985916","doi-asserted-by":"publisher","DOI":"10.12809\/hkjr2017181"},{"key":"bibr58-1078155220985916","unstructured":"Yih P, Mak S. Ambulatory home chemotherapy programme \u2013 a success story | Latest news for Doctors, Nurses and Pharmacists | Oncology, https:\/\/specialty.mims.com\/topic\/ambulatory-home-chemotherapy-programme, (accessed 21 December 2020)."},{"key":"bibr59-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1191\/1078155202jp092oa"},{"key":"bibr60-1078155220985916","unstructured":"Hong Kong Society of Clinical Oncology. New Study in Hong Kong Shows Home Ambulatory Chemotherapy Improves Cancer Patient\u2019s Quality of Life-PR Newswire APAC, https:\/\/en.prnasia.com\/releases\/apac\/new-study-in-hong-kong-shows-home-ambulatory-chemotherapy-improves-cancer-patient-s-quality-of-life-262441.shtml (2019, (2019, accessed 21 December 2020)."},{"key":"bibr61-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1374936"},{"key":"bibr62-1078155220985916","unstructured":"Salman D, Gomes B, Di Paolo A, et\u00a0al. B148: optimising ambulatory chemotherapy services: a system for monitoring drug delivery in elastomeric pumps. In: NCRI Cancer Conference, https:\/\/abstracts.ncri.org.uk\/abstract\/optimising-ambulatory-chemotherapy-services-a-system-for-monitoring-drug-delivery-in-elastomeric-pumps-2\/ (2015, accessed 21 December 2020)."},{"key":"bibr63-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216656928"},{"key":"bibr64-1078155220985916","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216687153"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220985916","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155220985916","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220985916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:24:31Z","timestamp":1777688671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155220985916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1177\/1078155220985916"],"URL":"https:\/\/doi.org\/10.1177\/1078155220985916","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]}}}